User profiles for José L. Pablos

Jose Luis Pablos

Hospital 12 de Octbre, IMAS12, UCM
Verified email at ucm.es
Cited by 9356

WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12

K Balabanian, B Lagane, JL Pablos, L Laurent… - Blood, 2005 - ashpublications.org
The WHIM syndrome is a rare immunodeficiency disorder characterized by warts,
hypogammaglobulinemia, infections, and myelokathexis. Dominant heterozygous mutations of the …

[HTML][HTML] Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

…, L Puig, E Daudén, JD Cañete, JL Pablos… - Autoimmunity …, 2020 - Elsevier
Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of intensive
research because of its crucial role in the pathogenesis of different diseases across many …

Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin

JL Pablos, A Amara, A Bouloc, B Santiago… - The American journal of …, 1999 - Elsevier
Stromal-cell derived factor or SDF-1 is a CXC chemokine constitutively expressed by
stromal bone marrow cell cultures that binds to the G-protein-coupled receptor CXCR4. SDF-1/…

[HTML][HTML] T cell migration in rheumatoid arthritis

…, G Cascio, P Lucas, JL Pablos… - Frontiers in …, 2015 - frontiersin.org
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation
in joints, associated with synovial hyperplasia and with bone and cartilage destruction. …

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

JL Pablos, M Galindo, L Carmona, A Lledó… - Annals of the …, 2020 - ard.bmj.com
Objectives The impact of inflammatory rheumatic diseases on COVID-19 severity is poorly
known. Here, we compare the outcomes of a cohort of patients with rheumatic diseases with a …

Decreased susceptibility to Fas‐induced apoptosis of systemic sclerosis dermal fibroblasts

…, M Galindo, M Rivero, JL Pablos - Arthritis & Rheumatism …, 2001 - Wiley Online Library
Objective To determine whether dysregulated apoptosis of systemic sclerosis (SSc)
fibroblasts contributes to progressive fibrosis by promoting fibroblast longevity. Methods We …

[HTML][HTML] Topical application of a peptide inhibitor of transforming growth factor-β1 ameliorates bleomycin-induced skin fibrosis

…, J Ruiz, J Prieto, F Borrás-Cuesta, JL Pablos - Journal of Investigative …, 2005 - Elsevier
Transforming growth factor-β (TGF-β) plays a crucial role in the pathogenesis of skin fibrotic
diseases. Systemic TGF-β inhibitors effectively inhibit fibrosis in different animal models; …

Antiangiogenic effects of anti–tumor necrosis factor α therapy with infliximab in psoriatic arthritis

JD Cañete, JL Pablos, R Sanmartí… - Arthritis & …, 2004 - Wiley Online Library
Objective Neovascularization, with an increased number of synovial vessels with a
characteristic morphology, seems to contribute to the progression of psoriatic arthritis (PsA). …

Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: a single‐center cohort study

…, J Martínez‐López, J Origüen, JL Pablos… - Journal of Medical …, 2021 - Wiley Online Library
Coronavirus disease 2019 (COVID‐19) can lead to a massive cytokine release. The use of
the anti‐interleukin‐6 receptor monoclonal antibody tocilizumab (TCZ) has been proposed in …

Ectopic lymphoid neogenesis in psoriatic arthritis

…, B Gil-Torregrosa, D Baeten, JL Pablos - Annals of the …, 2007 - ard.bmj.com
Background: Ectopic lymphoid neogenesis (LN) occurs in rheumatoid synovium, where it is
thought to drive local antigen-dependent B cell development and autoantibody production. …